LIXTE Shares Are Trading Higher After the Company Announced the Publication of Pre-clinical Data on Its Lead Clinical Compound, LB-100
LIXTE宣布公布其主要临床化合物 LB-100 的临床前数据后,该公司股价走高
LIXTE Shares Are Trading Higher After the Company Announced the Publication of Pre-clinical Data on Its Lead Clinical Compound, LB-100
LIXTE宣布公布其主要临床化合物 LB-100 的临床前数据后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧